Autres langues Silence Therapeutics plc

Actions

SLN

US82686Q1013

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 25/09/2026			Varia. 5j.	Varia. 1 janv.
11,18 ^USD	-0,36%		-8,36%	+83,88%

23/09	Les actions européennes négociées aux États-Unis sous forme d’American depositary receipts reculent dans les échanges de mercredi	MT
22/09	Les actions européennes cotées aux États-Unis sous forme d’American Depositary Receipts reculent dans les échanges de mardi	MT

Autres langues

23/09	European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
22/09	European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
17/09	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
15/09	European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
11/09	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
09/09	European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
09/09	Gestern an der Wall Street: Geopolitik belastet den Wochenauftakt
09/09	Ayer en Wall Street: la geopolítica lastra el inicio de la semana
08/09	European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
02/09	Silence Therapeutics to Participate in Three September Investor Conferences
31/08	European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading
25/08	European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading
18/08	European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading
17/08	Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters Option to Purchase Additional ADSs
14/08	Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
13/08	European Equities Traded in the US Rise in Thursday Trading
12/08	UK's Silence Therapeutics Prices $175 Million Offering in US
12/08	Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
11/08	European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
11/08	Silence Therapeutics' Divesiran Data Support Best-in-Class Potential, Morgan Stanley Says
10/08	Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
10/08	Silence Therapeutics' Divesiran to Treat Polychthemia Vera Meets Primary, Secondary Endpoints
10/08	Top Midday Gainers
10/08	European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading
10/08	Silence Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026